Table 1.
2 h |
6 h |
||||||
---|---|---|---|---|---|---|---|
GeneSymbol | Genbank accession | P-value | log2FC | GeneSymbol | Genbank accession | P-value | log2FC |
Most up-regulated by BSO (Group 1) | |||||||
Ptpn14a | NM_008976 | <0.0001 | 1.85 | Hunk | NM_015755 | <0.0001 | 1.97 |
Serpinb1ba | NM_173052 | <0.0001 | 1.60 | Serpinb1ba | NM_173052 | 0.0002 | 1.85 |
Ccdc54a | NM_027046 | 0.0100 | 1.31 | Gclma | NM_008129 | <0.0001 | 1.80 |
Srxn1a | NM_029688 | <0.0001 | 1.28 | Hunk | NM_015755 | <0.0001 | 1.73 |
Tex19.1a | NM_028602 | <0.0001 | 1.22 | Ptpn14a | NM_008976 | <0.0001 | 1.52 |
Hunka | NM_015755 | 0.0007 | 1.14 | Serpina3g | NM_009251 | 0.0017 | 1.42 |
Esda | NM_016903 | 0.0002 | 1.14 | Slc39a4a | NM_028064 | <0.0001 | 1.40 |
Procr | NM_011171 | <0.0001 | 1.13 | Mep1aa | NM_008585 | 0.0032 | 1.21 |
Tfeca | NM_031198 | 0.0046 | 1.03 | Tfeca | NM_031198 | 0.0026 | 1.14 |
Slc7a11a | NM_011990 | <0.0001 | 1.00 | Prdx1 | NM_011034 | <0.0001 | 1.12 |
3110068a07rika | AK039947 | 0.0033 | 0.97 | Fosl1 | NM_010235 | 0.0082 | 1.11 |
Prdx1a | NM_011034 | <0.0001 | 0.97 | Gema | NM_010276 | 0.0275 | 1.09 |
Hunka | NM_015755 | 0.0008 | 0.94 | Slc7a11a | NM_011990 | <0.0001 | 1.07 |
Zdhhc18 | NM_001017968 | <0.0001 | 0.70 | Acta2a | NM_007392 | <0.0001 | 1.01 |
Zfpm2 | NM_011766 | 0.0006 | 0.69 | Vwce | NM_027913 | 0.0009 | 1.00 |
Most down-regulated by BSO (Group 2) | |||||||
Sox14 | NM_011440 | 0.0093 | −1.52 | Nup62cl | NM_001081668 | <0.0001 | −4.34 |
Olfr1412 | NM_146277 | 0.0005 | −1.51 | Psg26a | NM_001029893 | <0.0001 | −4.21 |
il1b | NM_008361 | 0.0004 | −1.49 | Kif12a | NM_010616 | 0.0052 | −2.56 |
Fabp2 | NM_007980 | 0.0093 | −1.48 | LOC102634429 | XM_006521612 | 0.0244 | −2.29 |
Mx2 | NM_013606 | 0.0329 | −1.39 | C230030N03Rik | AK082264 | 0.0034 | −2.22 |
Otor | NM_020595 | 0.0017 | −1.29 | Pdia2 | NM_001081070 | 0.0068 | −1.79 |
Zfp811 | NM_183177 | 0.0021 | −1.13 | Adrbk2 | AK048763 | 0.0125 | −1.65 |
Edn1 | NM_010104 | 0.0003 | −1.04 | Glipr1l1 | NM_027018 | 0.0052 | −1.56 |
Il4i1 | NM_010215 | 0.0003 | −1.04 | Urah | NM_029821 | 0.0103 | −1.36 |
Oas2 | NM_145227 | <0.0001 | −1.03 | Urah | NM_029821 | 0.0168 | −1.25 |
5830411N06Rik | AK030813 | 0.0022 | −1.00 | Cabp4 | NM_144532 | 0.0129 | −1.20 |
Zfp46 | NM_009557 | 0.0031 | −0.99 | Tcp10c | NM_001167578 | 0.0050 | −1.18 |
Irf7 | NM_016850 | 0.0383 | −0.92 | ND6 | AK140300 | <0.0001 | −1.13 |
Saa3 | NM_011315 | 0.0015 | −0.89 | Adora2a | NM_009630 | 0.0021 | −1.07 |
Pdgfb | NM_011057 | 0.0002 | −0.86 | Faaha | NM_010173 | 0.0023 | −0.94 |
Transcripts were selected for their differential expression between the two groups BSO + LPS vs LPS alone (cutoff was: FC, 1.5; P < 0.05 by one-way ANOVA, followed by a correction for multiple comparisons by controlling the false discovery rate with the two-stage step-up method of Benjamini, Krieger, and Yekutieli). Data for both 2 and 6 h are reported. Only the top 15 transcripts most affected by BSO (sorted by FC) are shown.
aTranscripts that are also significantly affected by BSO alone (BSO vs control, with a cutoff of FC 1.5, P < 0.05 as above). The full list can be seen in File S1 in Supplementary Material. Transcripts in bold were selected for PCR validation.
ANOVA, analysis of variance; BSO, buthionine sulfoximine: FC, fold change; LPS, lipopolysaccharide.